In part two of this two-part series, Dr. Stacey Clardy talks with Dr. Andrew Mammen about treatment options, real-world case studies, and future directions in myositis research.

Disclosures can be found at Neurology.org.

In part one of this two-part series, Dr. Stacey Clardy talks with Dr. Andrew Mammen about the different types of myositis, approaches to diagnosis, available diagnostic tools, and the evolving roles of MRI and biopsy in clinical practice.

Disclosures can be found at Neurology.org.

The September 2025 Recall replay highlights four previously released episodes focused on epilepsy. Dr. Halley Alexander begins the series with Dr. Juan Luis Alcala-Zermeno, discussing outcomes of epilepsy surgery in patients with tonic-clonic seizures. She then speaks with Dr. Samuel W. Terman about patients’ perceived seizure risk, seizure risk tolerance, and approaches to risk counseling. In the third episode, Dr. Alexander is joined by Dr. Vineet Punia to explore factors influencing the decision to continue or discontinue anti-seizure medications at discharge for patients hospitalized with acute symptomatic seizures. The replay concludes with Dr. Katie Krulisky’s conversation with Dr. Leah Blank on how outpatient follow-up impacts readmission rates in older adults with epilepsy or seizures

Podcast links:

The Effect of Epilepsy Surgery on Tonic–Clonic Seizures

Patient Perspectives on Antiseizure Medication Discontinuation

Understanding Acute Symptomatic Seizures

Outpatient Follow-Up With 30-Day Readmission After Epilepsy or Seizure Discharge

Article links:

The Effect of Epilepsy Surgery on Tonic–Clonic Seizures

Patient Perspectives on Antiseizure Medication Discontinuation

Antiseizure Medication Use and Outcomes After Suspected
or Confirmed Acute Symptomatic Seizures

Association of Outpatient Follow-Up With 30-Day Readmission After Epilepsy or Seizure Discharge in Medicare Beneficiaries Aged 65 and Older

Disclosures can be found at Neurology.org.